Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis

Y Zheng, S Li, X Liu, GYH Lip, L Guo… - Thrombosis and …, 2023 - thieme-connect.com
Background The aim of the present meta-analysis was to evaluate the effectiveness and
safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …

Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis.

Y Zheng, S Li, X Liu, GYH Lip, L Guo… - Thrombosis and …, 2023 - europepmc.org
Background The aim of the present meta-analysis was to evaluate the effectiveness and
safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …

Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis

Y Zheng, S Li, X Liu, GYH Lip, L Guo… - Thrombosis and …, 2023 - vbn.aau.dk
Background: The aim of the present meta-analysis was to evaluate the effectiveness and
safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …

Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis

Y Zheng, S Li, X Liu, GYH Lip, L Guo… - Thrombosis and … - pubmed.ncbi.nlm.nih.gov
Background The aim of the present meta-analysis was to evaluate the effectiveness and
safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …